Growth, survival and migration: the Trk to cancer.
Rubin
Joshua B
JB
Department of Pediatric Oncology, Dana Farber Cancer Institute, Department of Neurobiology, Harvard Medical School, Boston, Massachusetts, USA.
Segal
Rosalind A
RA
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002455:Cell Division / Q000502:physiology*; D002465:Cell Movement / Q000502:physiology*; D002470:Cell Survival / Q000502:physiology*; D006801:Humans; D009369:Neoplasms / Q000503:physiopathology* / Q000517:prevention & control; D020917:Receptor, trkA / Q000502:physiology*; D015398:Signal Transduction
D000970:Antineoplastic Agents; D020917:Receptor, trkA